老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ASLAN PHARMACEUTICALS LIMITED SPON ADS EACH REP 25 ORD SHS (P/S)

0.6000
+0.0000
成交量：- -
成交额：- -
市值：169.70万
市盈率：-0.04
高：0.6000
开：0.6000
低：0.6000
收：0.6000
数据加载中...
总览公司新闻公告
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/16

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多